Malabre Richard C bought AKBA
January 31, 2024 · Form 4 insider transaction
Malabre Richard C bought 223,950 shares of Akebia Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
223,950
Price
$0.00
Total value
N/A
InsiderMalabre Richard C
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2024
Filing dateFebruary 2, 2024
Shares owned after223,950
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.